Interní Med. 2010; 12(3): 145-147

Familial adenomatous polyposis - recommendations for screening and follow-up

MUDr.Jan Trna1, MUDr.Oldřich Stibůrek1, MUDr.Kateřina Klímová1, MUDr.Martina Mišejková1, MUDr.Jan Šlapák1, MUDr.Oldřich Robek2
1 Interní hepato-gastroenterologická klinika, LF MU a FN Brno
2 Chirurgická klinika LF MU a FN Brno

Familial adenomatous polyposis primarily endangers its carriers with development of colonic cancer. However, the extracolonic involvement

associated with this disease can also have serious consequences for patients. Recognition of a causal connection of extracolonic

findings with the basic diagnosis of familial adenomatous polyposis can lead to early diagnosis and well-timed surgical treatment of

asymptomatic patients without a family history of familial adenomatous polyposis and/or colorectal cancer. The article further proposes

a system of patients follow-ups after successful surgical treatment.

Keywords: familial adenomatous polyposis, screening, follow-up, chemoprofylaxis

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Trna J, Stibůrek O, Klímová K, Mišejková M, Šlapák J, Robek O. Familial adenomatous polyposis - recommendations for screening and follow-up. Interní Med. 2010;12(3):145-147.
Download citation

References

  1. Vokurka J, Adam Z, Žaloudík J, et al. Kolorektální karcinom. In: Adam Z, Vorlíček J, a kol. Speciální onkologie, 2002, s. 80-93.
  2. Croner RS, Brueckl WM, Reingruber B, et al. Age and manifestation related symptoms in familial adenomatous polyposis. BMC Cancer 2005; 5: 24. Go to original source... Go to PubMed...
  3. Jirásek V. Nemoci tlustého střeva. In: Klener P, a kol. Vnitřní lékařství, 2001, s. 499-450.
  4. Delaini GG, Scaglia M, Colucci G. The ileoanal pouch procedure in the long-term perspective: a critical review. Tech Coloproctol 2005; 9: 187-192. Go to original source... Go to PubMed...
  5. Groves CJ, Beveridge IG, Swain DJ, et al. Prevalence nad morphology of pouch and ileal adenomas in familial adenomatous polyposis. Dis Colon Rectum 2005; 48: 816-823. Go to original source... Go to PubMed...
  6. Schulz AC, Bojarski C, Buhr HJ. Occurence of adenomas in the pouch and small intestine of FAP patients after proctocolectomy with ileoanal pouch construction. Int J Colorectal Dis 2008; 23: 437-441. Go to original source... Go to PubMed...
  7. Groen EJ, Roos A, Muntinghe FL, et al. Extra-intestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol 2008; 15: 2439-2450. Go to original source... Go to PubMed...
  8. Novotný A, Bortlík M, Chroust K, et al. Komplexní přístup k pacientům s familiární adenomatozní polypozou - FAP registr. Čes Slov Gastroenterol Hepatol 2008; 62(Suppl. 3): 24.
  9. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial polyposis. Dis Colon Rectum 1993; 36: 1059-1062. Go to original source... Go to PubMed...
  10. Gallagher MC, Phillips RK, Bulow S. Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer 2006; 5: 263-273. Go to original source... Go to PubMed...
  11. Offerhaus GJA, Entius MM, Giardiello FM. Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 1999; 46: 667-669. Go to PubMed...
  12. Iaquinto G, Fornasarig M, Quaia M, et al. Capsule endoscopy is useful and safe for small-bowel surveillance in FAP. Gastrointest Endosc 2008; 67: 61-67. Go to original source... Go to PubMed...
  13. Saurin JC, Gutknecht C, Napoleon B, et al. Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol 2004; 22: 493-498. Go to original source... Go to PubMed...
  14. Arvanitis ML, Jagelman DG, Fazio VW. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639-642. Go to original source... Go to PubMed...
  15. Clark SK, Philips RKS. Desmoids in familial adenomatous polyposis. Br J Surg 1996; 83: 1494-1504. Go to original source... Go to PubMed...
  16. Nieuwenhuis MH, De Vos Tot Nederveen Cappel W, Botma A, et al. Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008; 6: 215-219. Go to original source... Go to PubMed...
  17. Knudsen AL, Bülow S. Desmoid tumour in familial adenomatous polyposis. A review of literature. Fam Cancer 2001; 1: 111-119. Go to original source... Go to PubMed...
  18. Herraiz M, Barbesino G, Faquin W, et al. Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol 2007; 5: 367-373. Go to original source... Go to PubMed...
  19. Harach HR, Williams GT, Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm. Histopathology 1994; 25: 549-561. Go to original source... Go to PubMed...
  20. Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993; 34: 1394-1396. Go to original source... Go to PubMed...
  21. Elkharwily A, Gottlieb K. The Pancreas in Familial Adenomatous Polyposis. JOP. J Pancreas (Online) 2008; 9: 9-18.
  22. Trna J, Dítě P, Hermanová M, Ševčíková A. Výskyt diabetes mellitus u pacientů s karcinomem slinivky břišní. Čes Slov Gastroenterol Hepatol 2008; 62: 69-74.
  23. Borch-Johnsen K, Olsen JH, S?rensen TI. Genes and family environment in familial clustering of cancer. Theor Med 1994; 15: 377-386. Go to original source... Go to PubMed...
  24. Oshima M, Dinchuk JE, Kargman SL, Oshima H, et al. Suppresion of intestinal polyposis in APC knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-809. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.